Pulmonx Corporation (LUNG) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
Pulmonx Corporation (LUNG) operates in the Healthcare sector, specifically the Medical - Devices industry, with a market capitalization near $56.2M, listed on NASDAQ, employing roughly 291 people, carrying a beta of 0.18 to the broader market. Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. Led by Glendon E. French, public since 2020-10-01.
Snapshot as of May 15, 2026.
- Spot Price
- $1.27
- Total OI
- 4.2K